Skip to main content
Top

Open Access 21-02-2024 | Yersina Enterocolitica | Original Article

Seek and you shall find: Yersinia enterocolitica in Ireland’s drinking water

Authors: James Powell, Maureen Daly, Nuala H. O’Connell, Colum P. Dunne

Published in: Irish Journal of Medical Science (1971 -)

Login to get access

Abstract

Introduction

Three Yersinia species were identified from samples of drinking water from diverse geographic regions of Ireland. Conventional commercial biochemical identification systems classified them as Yersinia enterocolitica. Since this organism is the most common cause of bacterial gastroenteritis in some countries, further investigation was warranted. The aim of the study was to provide a microbial characterisation of three Yersinia species, to determine their pathogenicity, and to review the incidence rate of Yersinia enterocolitica detection in our region.

Methods

Organism identification was performed using conventional commercial diagnostic systems MALDI-TOF, API 20E, API 50CHE, TREK Sensititre GNID and Vitek 2 GN, and whole genome sequencing (WGS) was performed. Historical data for detections was extracted from the lab system for 2008 to 2023.

Results

All three isolates gave “good” identifications of Yersinia enterocolitica on conventional systems. Further analysis by WGS matched two of the isolates with recently described Yersinia proxima, and the third was a member of the non-pathogenic Yersinia enterocolitica clade 1Aa.

Discussion

Our analysis of these three isolates deemed them to be Yersinia species not known currently to be pathogenic, but determining this necessitated the use of next-generation sequencing and advanced bioinformatics. Our work highlights the importance of having this technology available to public laboratories, either locally or in a national reference laboratory. The introduction of molecular technologies for the detection of Yersinia species may increase the rate of detections. Accurate identification of significant pathogens in environmental, public health and clinical microbiology laboratories is critically important for the protection of society.
Appendix
Available only for authorised users
Literature
1.
go back to reference Adeolu M, Alnajar S, Naushad S, S. Gupta R (2016) Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol 66:5575–5599. https://doi.org/10.1099/ijsem.0.001485CrossRefPubMed Adeolu M, Alnajar S, Naushad S, S. Gupta R (2016) Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol 66:5575–5599. https://​doi.​org/​10.​1099/​ijsem.​0.​001485CrossRefPubMed
13.
go back to reference Daly M, Powell J, O’Connell NH et al (2023) Antimicrobial resistance is prevalent in E.coli and other enterobacterales isolated from public and private drinking water supplies in the republic of ireland. Microorganisms 11:1224CrossRefPubMedPubMedCentral Daly M, Powell J, O’Connell NH et al (2023) Antimicrobial resistance is prevalent in E.coli and other enterobacterales isolated from public and private drinking water supplies in the republic of ireland. Microorganisms 11:1224CrossRefPubMedPubMedCentral
14.
go back to reference International Organization for Standardization (2012) Water quality—detection and enumeration of Escherichia coli and coliform bacteria—part 2: membrane filtration method. Available online: https://www.iso.org/home.html. Accessed on 28 Dec 2022 International Organization for Standardization (2012) Water quality—detection and enumeration of Escherichia coli and coliform bacteria—part 2: membrane filtration method. Available online: https://​www.​iso.​org/​home.​html. Accessed on 28 Dec 2022
32.
go back to reference Schindler PR (1984) Isolation of Yersinia enterocolitica from drinking water in South Bavaria. Zentralbl Bakteriol Mikrobiol Hyg B 180:76–84PubMed Schindler PR (1984) Isolation of Yersinia enterocolitica from drinking water in South Bavaria. Zentralbl Bakteriol Mikrobiol Hyg B 180:76–84PubMed
35.
go back to reference Weber G, Stanek G, Massiczek N, Klenner MF (1981) Yersinia enterocolitica in drinking water. Zentralbl Bakteriol Mikrobiol Hyg B 173:209–216PubMed Weber G, Stanek G, Massiczek N, Klenner MF (1981) Yersinia enterocolitica in drinking water. Zentralbl Bakteriol Mikrobiol Hyg B 173:209–216PubMed
36.
go back to reference Luppi A, Gaiani R (1979) Isolation of Yersinia enterocolitica from drinking water and human feces. Boll Ist Sieroter Milan 58:391–394PubMed Luppi A, Gaiani R (1979) Isolation of Yersinia enterocolitica from drinking water and human feces. Boll Ist Sieroter Milan 58:391–394PubMed
37.
go back to reference Eden KV, Rosenberg ML, Stoopler M et al (1977) Waterborne gastrointestinal illness at a ski resort. –Isolation of Yersinia enterocolitica from drinking water. Public Health Rep 92:245–250PubMedPubMedCentral Eden KV, Rosenberg ML, Stoopler M et al (1977) Waterborne gastrointestinal illness at a ski resort. –Isolation of Yersinia enterocolitica from drinking water. Public Health Rep 92:245–250PubMedPubMedCentral
Metadata
Title
Seek and you shall find: Yersinia enterocolitica in Ireland’s drinking water
Authors
James Powell
Maureen Daly
Nuala H. O’Connell
Colum P. Dunne
Publication date
21-02-2024
Publisher
Springer International Publishing
Published in
Irish Journal of Medical Science (1971 -)
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-024-03641-5
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine